Unirisco helps to reduce the risk when starting up a business, right from the university.

Mabel Loza – Oncostellae


Oncostellae is a biotech company specialized in the development of new drugs for the treatment of certain diseases in oncology and autoimmune diseases, such as prostate cancer, Inflammatory Bowel Disease (IBM), psoriasis and severe asthma.

The company’s business model focuses on the discovery of new drugs and on their development from the initial stages to the proof of concept in patients (clinical Phase Ib/IIa) in order to license the results and patents to pharmaceutical companies.